AI-powered blood test first to spot earliest sign of breast cancer
A study suggests a new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer
A study suggests a new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer
The study was commissioned and funded by the National Institute for Health and Care Research (NIHR), and its leading partners were The University of Manchester, Northern Care Alliance NHS Foundation Trust and Warwick Medical School’s Clinical Trials Unit, who specialize in research in emergency and critical care
Find out how CLINICAL24 supporter, ADLM, advances clinical laboratory medicine by empowering laboratory professionals
T2 Biosystems announces plans to license its proprietary technology to accelerate the broad adoption of direct-from-whole-blood diagnostics, generate non-dilutive capital, and create a new royalty revenue stream
Find out which products have earned a new Seal of Quality, including the rare Diamond Seal of Quality
Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development
High-throughput platform accelerates drug discovery by reducing the number of manual steps by up to 90%
Tell us which new products have had the biggest impact on your lab work for a chance to win one of five $100 Amazon.com Gift Cards
Explore FUJIFILM Wako comprehensive range of tools for microglia, Alzheimer’s, and depression research
Research at Karl Landsteiner University of Health Sciences offers new insight in brain connectivity and development
Learn how BioApp Solutions enhances liquid handling efficiency with INTEGRA Biosciences' pipettes
The PATHWAY HER2 (4B5) test helps identify patients with previously treated, unresectable or metastatic HER2-positive biliary tract cancer (BTC) who may be eligible for treatment with ZIIHERA
The expansion enhances Abzena’s extensive bioassay offering, providing customers with a more comprehensive, streamlined, and cost-effective way to access critical data faster
Join us as we raise awareness of the medical lab profession with a global one day publishing event
Patient blood management experts share how nuanced approaches beyond following hemoglobin thresholds can help lead to better patient outcomes
GERSTEL joins AAT’s portfolio of leading brands, including Skalar Analytical, LCTech, PromoChrom, EST Analytical, and tsHR, boosting global reach and expanding product and service offerings
The latest updates support cryo-correlative light and electron microscopy (cryo-CLEM) and allows researchers to investigate samples at cryogenic temperatures down to <–195°C
A solution for infectious disease research, delivering rapid, flexible, and scalable pathogen detection
The strategic partnership combines cutting-edge molecular profiling technology with unparalleled biospecimen and tissue profiling services
Aims to streamline clinical lab workflows with integrated tissue enrichment and nucleic acid purification solutions
CancerKB 4.0 promises comprehensive, report-ready diagnostic, prognostic, and therapeutic insights for hematological cancers, streamlining workflows with curated data from NCCN, WHO, and more
Discover how Siemens Healthineers is breaking down barriers and making automation more accessible, efficient, and beneficial for clinical labs of all sizes